NEW YORK (GenomeWeb) – Syntekabio, a bioinformatics startup from South Korea, said today that it has closed a ₩12 billion ($11.2 million) Series B round of venture capital. Smilegate Investment led the round, with participation from the Korea Development Bank, Korea Fixed-Income Investment Advisory, The Yozma Group Korea, and previous investor Altos Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.